Literature DB >> 26823866

Association of PTEN gene polymorphisms with liver cancer risk.

Hong-Guang Li1, Fang-Feng Liu1, Hua-Qiang Zhu1, Xu Zhou1, Jun Lu1, Hong Chang1, Jin-Hua Hu2.   

Abstract

OBJECTIVE: To find out if there are any relationship between three single nucleotide polymorphisms (SNPs) of phosphatase and tensin homolog (PTEN) gene (rs1234213, rs1234220, and rs2299939) and the susceptibility of liver cancer.
METHODS: Genotypes of the three SNPs in the PTEN gene were achieved utilizing polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Comparison of genotypes and alleles distribution differences between the case and the control subjects was accomplished with χ(2) test. The analysis of linkage disequilibrium (LD) and haplotypes of the three SNPs was performed using SHEsis software. We adopted odds ratios (ORs) with 95% confidence intervals (95% CIs) to show the relative risk of liver cancer.
RESULTS: TC genotype and C allele of rs1234220 polymorphism showed much more frequently in cases than in controls, reflecting that the TC genotype and the C allele may be linked to the increased risk of liver cancer (OR=2.225, 95% CI=1.178-4.204; OR=1.941, 95% CI=1.124-3.351). Rs2299939 polymorphism showed an opposite result that the GT genotype probably reduce the risk of liver cancer (OR=0.483, 95% CI=0.259-0.900). Statistical significance was not found in the distribution differences of the genotypes of rs1234213 between two groups. LD and haplotype analysis results of the three SNPs showed that the T-C-G haplotype frequency was much higher in cases than in healthy objects, which proved that the T-C-G haplotype might be a susceptibility haplotype for liver cancer (OR=3.750, 95% CI=1.396-10.077).
CONCLUSIONS: PTEN gene polymorphisms might relate to liver cancer risk.

Entities:  

Keywords:  PTEN; haplotype; liver cancer; polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26823866      PMCID: PMC4713652     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  28 in total

1.  Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia.

Authors:  P Y Jotta; M A Ganazza; A Silva; M B Viana; M J da Silva; L J G Zambaldi; J T Barata; S R Brandalise; J A Yunes
Journal:  Leukemia       Date:  2009-10-15       Impact factor: 11.528

2.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

Review 3.  SNP alleles in human disease and evolution.

Authors:  Barkur S Shastry
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

4.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

Review 5.  PTEN regulatory functions in tumor suppression and cell biology.

Authors:  Eric C Chu; Andrzej S Tarnawski
Journal:  Med Sci Monit       Date:  2004-09-23

6.  Suppression of PTEN expression by NF-kappa B prevents apoptosis.

Authors:  Krishna Murthi Vasudevan; Sushma Gurumurthy; Vivek M Rangnekar
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

7.  Association of NFKB1, which encodes a subunit of the transcription factor NF-kappaB, with alcohol dependence.

Authors:  Howard J Edenberg; Xiaoling Xuei; Leah Flury Wetherill; Laura Bierut; Kathleen Bucholz; Danielle M Dick; Victor Hesselbrock; Sam Kuperman; Bernice Porjesz; Marc A Schuckit; Jay A Tischfield; Laura A Almasy; J I Nurnberger; Tatiana Foroud
Journal:  Hum Mol Genet       Date:  2007-12-12       Impact factor: 6.150

Review 8.  PTEN at the crossroad of metabolic diseases and cancer in the liver.

Authors:  Manlio Vinciguerra; Michelangelo Foti
Journal:  Ann Hepatol       Date:  2008 Jul-Sep       Impact factor: 2.400

9.  A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China.

Authors:  G S Qian; R K Ross; M C Yu; J M Yuan; Y T Gao; B E Henderson; G N Wogan; J D Groopman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994 Jan-Feb       Impact factor: 4.254

10.  Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model.

Authors:  Guangyao Kong; Junping Zhang; Shuai Zhang; Changliang Shan; Lihong Ye; Xiaodong Zhang
Journal:  PLoS One       Date:  2011-05-05       Impact factor: 3.240

View more
  4 in total

1.  Lack of relationship between PTEN 32-bp and TP53 16-bp Ins/Del polymorphisms and chronic hepatitis B virus infection.

Authors:  Ebrahim Eskandari; Tayebeh Dahmardeh; Fatemeh Dahmardeh; Elham Pahlevani; Malihe Metanat
Journal:  Virusdisease       Date:  2017-08-22

2.  Association of phosphatase and tension homologue deleted on chromosome ten polymorphism rs1903858, but not serum levels with the risk of non-small-cell lung cancer: A case-control study.

Authors:  Zhen Liang; Yuzhu Tang; Hao Li; Youjun Xie; Lingling Zhan
Journal:  J Clin Lab Anal       Date:  2020-06-15       Impact factor: 2.352

3.  PTEN gene silencing contributes to airway remodeling and induces airway smooth muscle cell proliferation in mice with allergic asthma.

Authors:  Xin Wen; Jing Yan; Xin-Rui Han; Gui-Hong Zheng; Ran Tang; Li-Fang Liu; Dong-Mei Wu; Jun Lu; Yuan-Lin Zheng
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 3.005

4.  MIR17HG polymorphism (rs7318578) is associated with liver cancer risk in the Chinese Han population.

Authors:  Xu Chao; Xuesong Feng; Hailong Shi; Yuewen Wang; Lanlan Wang; Haiyu Shen; Qing Zha; Yanni Chen; Chao Jiang
Journal:  Biosci Rep       Date:  2020-08-28       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.